Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
Subjects with a history of recurrent herpes labialis will be sensitized with either 2% SADBE
or placebo. Following this, subjects sensitized with 2% SADBE will received.2% sqauric acid
or.5% squaric acid on their cold sore within 72 hours of a recurrence. Subjects sensitized
with placebo solution will receive placebo solution on their cold sore within 72 hours of a
recurrence. Subjects will be followed for up to 6 mos after application of study medication.